BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23864039)

  • 1. Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.
    Nandagudi A; Jury EC; Alonzi D; Butters TD; Hughes S; Isenberg DA
    Lupus; 2013 Sep; 22(10):1070-6. PubMed ID: 23864039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney involvement in systemic lupus erythematosus and Fabry's disease.
    Rosenmann E; Kobrin I; Cohen T
    Nephron; 1983; 34(3):180-4. PubMed ID: 6410291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of Fabry's disease and systemic lupus erythematosus.
    Rahman P; Gladman DD; Wither J; Silver MD
    Clin Exp Rheumatol; 1998; 16(4):475-8. PubMed ID: 9706432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Long-term outcome post-heart transplantation in a woman with Fabry's disease.
    Verocai F; Clarke JT; Iwanochko RM
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S385-7. PubMed ID: 20852936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac transplantation for Fabry's disease.
    Cantor WJ; Daly P; Iwanochko M; Clarke JT; Cusimano RJ; Butany J
    Can J Cardiol; 1998 Jan; 14(1):81-4. PubMed ID: 9487277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of thrombosis in Fabry's disease.
    Utsumi K; Yamamoto N; Kase R; Takata T; Okumiya T; Saito H; Suzuki T; Uyama E; Sakuraba H
    Intern Med; 1997 May; 36(5):327-9. PubMed ID: 9213168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline of plasma brain natriuretic peptide during enzyme replacement therapy in a female patient with heterozygous Fabry's disease.
    Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Murao K; Kohno M; Itoh S
    Tohoku J Exp Med; 2009 Mar; 217(3):169-74. PubMed ID: 19282651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopsy-proven cardiomyopathy in heterozygous Fabry's disease.
    Koitabashi N; Utsugi T; Seki R; Okamoto E; Sando Y; Kaneko Y; Nagai R
    Jpn Circ J; 1999 Jul; 63(7):572-5. PubMed ID: 10462028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabry's disease presenting with stroke.
    Grewal RP; Barton NW
    Clin Neurol Neurosurg; 1992; 94(2):177-9. PubMed ID: 1324819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry's disease.
    Kawano M; Takenaka T; Otsuji Y; Teraguchi H; Yoshifuku S; Yuasa T; Yu B; Miyata M; Hamasaki S; Minagoe S; Kanmura Y; Tei C
    Am J Cardiol; 2007 Jan; 99(2):261-3. PubMed ID: 17223430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal vein occlusion in a woman with heterozygous Fabry's disease.
    Oto S; Kart H; Kadayifçilar S; Ozdemir N; Aydin P
    Eur J Ophthalmol; 1998; 8(4):265-7. PubMed ID: 9891901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Four cases of Fabry's disease mimicking hypertrophic cardiomyopathy].
    Tanaka H; Adachi K; Yamashita Y; Toshima H; Koga Y
    J Cardiol; 1988 Sep; 18(3):705-18. PubMed ID: 2977798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fabry's disease associated with rheumatoid arthritis. Multisystemic crossroads].
    Arias Martínez N; Barbado Hernández FJ; Pérez Martín G; Pérez de Ayala C; Casal Esteban V; Vázquez Rodríguez JJ
    An Med Interna; 2003 Jan; 20(1):28-30. PubMed ID: 12666306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary involvement in Fabry's disease.
    Koskenvuo JW; Kantola IM; Nuutila P; Knuuti J; Parkkola R; Mononen I; Hurme S; Kalliokoski R; Viikari JS; Wendelin-Saarenhovi M; Kiviniemi TO; Hartiala JJ
    Acta Cardiol; 2010 Apr; 65(2):185-92. PubMed ID: 20458826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overt congestive heart failure with mitral and aortic regurgitation due to antiphospholipid syndrome in a patient with systemic lupus erythematosus.
    Morita H; Daido H; Suwa T; Mune T; Yoshino K; Isomura Y; Tanahashi T; Takeda N; Ishizuka T; Yasuda K
    Intern Med; 2000 Jun; 39(6):506-11. PubMed ID: 10852175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey.
    Sodi A; Ioannidis AS; Mehta A; Davey C; Beck M; Pitz S
    Br J Ophthalmol; 2007 Feb; 91(2):210-4. PubMed ID: 16973664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allograft loss in renal transplant recipients with Fabry's disease and activated protein C resistance.
    Friedman GS; Wik D; Silva L; Abdou JC; Meier-Kriesche HU; Kaplan B; Bonomini L; DeFranco P; Lyman N; Mulgaonkar S; Jacobs M
    Transplantation; 2000 May; 69(10):2099-102. PubMed ID: 10852604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifteen-year follow-up of a heterozygous Fabry's disease patient associated with pre-excitation syndrome.
    Murata R; Takatsu H; Noda T; Nishigaki K; Tsuchiya K; Takemura G; Kanoh M; Kunishima A; Sano K; Minatoguchi S; Takagi H; Fujiwara H
    Intern Med; 1999 Jun; 38(6):476-81. PubMed ID: 10411352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease.
    Heltianu C; Costache G; Azibi K; Poenaru L; Simionescu M
    Clin Genet; 2002 Jun; 61(6):423-9. PubMed ID: 12121349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.